Investment Stage

Focus Areas

About Investor

Jonathan Tobin is a Partner at Brandon Capital, focusing on investments in Medical Devices, Pharmaceuticals, BioTech, Therapeutics, and Health & Hospital Services companies at pre-seed and seed stages. His investment range typically spans from $100K to $5M. Tobin holds a first-class Biology degree from Oxford, a PhD in Molecular Medicine from UCL, and an MBA from Imperial College London. He joined Brandon Capital in 2021 and heads the London office, serving on the boards of several portfolio companies. Previously, he was a Managing Director at Arix Bioscience where he built the team and portfolio, and has conducted postdoctoral research on cancer cell signalling at Cancer Research UK, publishing in Nature Genetics and NEJM.